Insight: How compounding pharmacies rallied patients to fight regulation
Reuters reports on the dangers of pharmacies that mix or alter drugs without proper federal oversight. As it stands, the safety and efficacy of drugs made by these “compounding pharmacies” make for red alerts. Dr. Steven Galson, a top official at the Food and Drug Administration, has shed some light on the risks from an industry that’s now at the heart of today’s unprecedented meningitis outbreak. Now, as deaths and illnesses from fungal meningitis are increasingly linked to a contaminated steroid injection, the question of why early concerns about pharmacy compounding did not change U.S. law is a top focus for patients, regulators and lawmakers. Rightly so, we believe.
To read more, click here.
(Image source)
